Hsiu Mei Huang
Directeur/Membre du Conseil chez TaiGen Biotechnology Co., Ltd.
Profil
Hsiu Mei Huang is an Independent Director at TaiGen Biotechnology Co., Ltd.
She previously served as an Independent Director at Taiwan Liposome Co., Ltd.
and TWi Pharmaceuticals, Inc. She also held positions as Managing Director at Glaxosmithkline and General Manager & Spokesman at OBI Pharma, Inc. Huang received her undergraduate degree from National Taiwan University.
Postes actifs de Hsiu Mei Huang
| Sociétés | Poste | Début |
|---|---|---|
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Directeur/Membre du Conseil | - |
Anciens postes connus de Hsiu Mei Huang
| Sociétés | Poste | Fin |
|---|---|---|
| Glaxosmithkline /Taiwan/ | Corporate Officer/Principal | - |
| OBI PHARMA, INC. | Directeur Général | - |
| TWI PHARMACEUTICALS INC | Directeur/Membre du Conseil | - |
| TAIWAN LIPOSOME COMPANY, LTD. | Directeur/Membre du Conseil | - |
Formation de Hsiu Mei Huang
| National Taiwan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OBI PHARMA, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
Taiwan Liposome Co., Ltd.
 Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
TWi Pharmaceuticals, Inc.
 TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
| Glaxosmithkline /Taiwan/ |
